Saturday, February 22, 2014 3:22:39 PM
"The article is non-factual on its face"
Not entirely. There are issues of corporate governance that are raised that shareholders should care about, especially since some of them involve NYSE MKT listing requirements (shareholder meetings and votes, for example).
The one that caught my attention, raised in the court case, was posed this way in the SA blog:
"Where are NNVC's original articles of incorporation and bylaws? They are referenced in the 10ks but we cannot find them filed with SEC as they claim anywhere."
The list of Exhibits at the end of every 10-K ever filed by the company has started with the following 2 items:
3.1* Articles of Incorporation, as amended, of the Registrant
3.2* By-laws of the Registrant
The asterisk is explained below the list:
* Incorporated by reference to the Company’s registration statement on Form 10-SB, filed with the Securities Commission on November 14, 2006, as amended.
http://www.sec.gov/Archives/edgar/data/1379006/000114420413053084/v356235_10k.htm
However, when one refers to the filing made on November 14, 2006, this is all they see:
3.1 Articles of Incorporation, as amended, of the Registrant
3.2 By-laws of the Registrant
http://www.sec.gov/Archives/edgar/data/1379006/000114420406047712/v057372_10sb.htm
The Articles and By-laws are on the list of Exhibits yet the documents themselves are not exhibited, as they should be.
These are documents that enumerate the rights of shareholders and the duties and obligations of the company and its agents. They must be filed with the SEC and made available to public....there's no possible justification for them not to be. It should not require a lawsuit to make that happen.
Not entirely. There are issues of corporate governance that are raised that shareholders should care about, especially since some of them involve NYSE MKT listing requirements (shareholder meetings and votes, for example).
The one that caught my attention, raised in the court case, was posed this way in the SA blog:
"Where are NNVC's original articles of incorporation and bylaws? They are referenced in the 10ks but we cannot find them filed with SEC as they claim anywhere."
The list of Exhibits at the end of every 10-K ever filed by the company has started with the following 2 items:
3.1* Articles of Incorporation, as amended, of the Registrant
3.2* By-laws of the Registrant
The asterisk is explained below the list:
* Incorporated by reference to the Company’s registration statement on Form 10-SB, filed with the Securities Commission on November 14, 2006, as amended.
http://www.sec.gov/Archives/edgar/data/1379006/000114420413053084/v356235_10k.htm
However, when one refers to the filing made on November 14, 2006, this is all they see:
3.1 Articles of Incorporation, as amended, of the Registrant
3.2 By-laws of the Registrant
http://www.sec.gov/Archives/edgar/data/1379006/000114420406047712/v057372_10sb.htm
The Articles and By-laws are on the list of Exhibits yet the documents themselves are not exhibited, as they should be.
These are documents that enumerate the rights of shareholders and the duties and obligations of the company and its agents. They must be filed with the SEC and made available to public....there's no possible justification for them not to be. It should not require a lawsuit to make that happen.
“I have had a wonderful time but this wasn't it.”
..........Groucho
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 10:01:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:30:33 PM
- NanoViricides Announces Closing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/19/2026 03:55:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/18/2026 12:45:22 PM
- Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides • ACCESS Newswire • 05/18/2026 12:30:00 PM
- NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/15/2026 12:35:00 PM
- NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II • ACCESS Newswire • 05/15/2026 12:00:00 PM
- Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides • ACCESS Newswire • 05/11/2026 12:30:00 PM
- NanoViricides, Inc. Announces Participation in the D. Boral Capital Global Conference • Newsfile • 05/06/2026 07:37:00 PM
- NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA • ACCESS Newswire • 05/04/2026 12:30:00 PM
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
